Imidazole derivatives as orexin antagonists, compositions and methods
The present disclosure relates to substituted imidazo [2, 1-b] oxazole, imidazo [2, 1-b] thiazole, imidazo [2, 1-b] oxadiazole, imidazo [2, 1-b] oxadiazole derivatives of compounds that are antagonists of orexin receptors and are useful in the treatment or prevention of neurological and psychiatric...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
05.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to substituted imidazo [2, 1-b] oxazole, imidazo [2, 1-b] thiazole, imidazo [2, 1-b] oxadiazole, imidazo [2, 1-b] oxadiazole derivatives of compounds that are antagonists of orexin receptors and are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which or associated with orexin receptors. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the prevention or treatment of diseases in which orexin receptors are involved.
本公开涉及化合物的取代的咪唑并[2,1-b]噁唑、咪唑并[2,1-b]噻唑、咪唑并[2,1-b]噁二唑、咪唑并[2,1-b]噁二噻唑衍生物,这些化合物是食欲肽受体的拮抗剂,并可用于治疗或预防涉及食欲肽受体或与食欲肽受体相关联的神经和精神障碍和疾病。本发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在预防或治疗涉及食欲肽受体的疾病中的用途。 |
---|---|
Bibliography: | Application Number: CN202080055282 |